Objective To prospectively examine dose-response and timing effects of prenatal (PTE) and postnatal tobacco exposure on obesity risk assessed by conditional weight-for-length gain (CWFLG), by 2 years of age. Methods CWFLG over the first 2 years of life was examined for 117 PTE and 57 nonexposed children. Repeated assessments of PTE were conducted beginning in the first trimester of pregnancy, using multiple methods. Results PTE or postnatal exposure status was not predictive of CWFLG. However, there was a dose-response association and an association with fetal exposure ascertained by infant meconium positive for nicotine and metabolites. Conclusions PTE is related to restricted growth at birth, yet associated with accelerated CWFLG by 2 years of age, a measure that controls for birthweight differences. Results highlight the importance of examining dose-response and timing of exposure associations, along with the importance of obesity riskreduction interventions within the first 2 years of life among PTE children.
Introduction
Rates of childhood obesity have been rising worldwide at a dramatic pace over the past few decades (Han, Lawlor, & Kimm, 2010; WHO, 2000) , with an estimated 17% (i.e., approximately 21.5 million) of American children and adolescents between the ages of 2 and 19 years meeting criteria for obesity (Ogden, Carroll, Curtin, Lamb, & Flegal, 2010) . This escalation in childhood obesity represents a significant public health threat. Childhood obesity is not only linked with adult obesity, but also with a greater risk of chronic disease later in life (Ebbeling, Pawlak, & Ludwing, 2002) . Although the etiology of childhood obesity is multifactorial, a growing body of research has established the importance of prenatal origins of health and disease, including the development of childhood obesity (Barker, 1992; Gillman et al., 2008) .
Prenatal Tobacco Exposure and Obesity Risk
One well-established prenatal risk factor of childhood obesity is prenatal tobacco exposure (PTE; Ino, 2010; Moller, Ajsley, Anderson, Dalgard, & Sorenson, 2014) . Although recent evidence indicates declines in cigarette consumption during pregnancy (Cnattingius, 2004) , the rates remain quite high, ranging from 18% to 27% of pregnant women (US Department of Health and Human Services, 2014, review) . PTE is consistently linked with intrauterine growth restriction and lower birthweights owing to a combination of high prenatal stress from fetal hypoxia and ischemia (U.S. Department of Health and Human Services, 2014, review) . Yet, research also supports that PTE increases the risk of childhood obesity, as PTE is routinely associated with greater weight, overweight, and body mass index (BMI) from infancy to adulthood (Oken, Levitan, & Gillman, 2008) . According to the thrifty phenotype hypothesis, a poor fetal environment characterized by less than optimal nutrition for the fetus can result in several downstream changes aimed at greater efficiency in storing energy. Some of these changes may include alterations in hypothalamic functioning along with lowered insulin secretion and insulin resistance, which are adaptive under conditions of continued malnutrition during the postnatal period, but can lead to greater risk of metabolic disease and obesity when the child is provided with adequate or an overabundance of nutrients (Genne-Bacon, 2014; Hale and Barker, 2001 ). In short, fetuses exposed to less than optimal in utero environments, such as those exposed to PTE, become "thrifty" in managing their energy stores to compensate for their earlier nutritional deprivation, which results in greater catch-up growth when these children are provided with adequate nutrition postnatally.
Rapid Weight Gain-A Marker for Obesity Risk
As indicated by the thrifty phenotype hypothesis, rapid weight gain in the first 2 years of life is a critical early indicator of later obesity risk (Monteiro & Victora, 2005) . Toddlers who demonstrate rapid gain are at higher risk of later obesity with relative risks ranging from 1.17 to 5.70 (Baird, Fisher, Lucas, Roberts, & Law, 2005; review) . Rapid weight gain is also associated with an increased risk for a host of later chronic diseases (Adair, 2007) . Moreover, many studies have reported strong robust associations between PTE and rapid weight gain (Nafstad et al., 1997; Zheng et al., 2015) , but few have targeted the first 2 years of life. This is important because early childhood intervention may be most effective in preventing obesity risk. Thus, taken together, previous studies provide compelling evidence that links rapid weight gain during the early years to later obesity and evidence of a robust association between PTE and later obesity.
Methodological Limitations
This literature, however, is methodologically limited and therefore we still lack insight into the complex associations between PTE and conditional weight-forlength gain (CWFLG). To our knowledge, only seven studies have used prospective designs examining the link between PTE and later obesity risk in children aged 6 years (Chen, Pennell, Klebanoff, Rogan, & Longnecker, 2006; Fasting et al., 2009; Harrod et al., 2014a; 2014b; Howe et al., 2012; Janjua, Mahmood, Islam, and Goldenberg, 2012; Oken, Huh, Taveras, Rich-Edwards, and Gillman, 2005) . Whereas each of these studies found support for the notion that PTE is associated with later obesity risk, each of these studies had methodological limitations. First, previous studies have relied solely on self-report measures of PTE. This may be problematic owing to underreporting of smoking during pregnancy (U.S. Department of Health & Human Services, 2014) . Further, unlike biological markers such as assaying nicotine metabolites in meconium, self-report data are limiting in that they do not assess actual fetal tobacco exposure. Second, previous studies have lacked demographically matched control groups, thereby introducing potential confounds. Tobacco use rates are particularly high among young, low-income, single women. Low income in particular is a significant, independent risk factor for childhood obesity (Penn & Owen, 2002) . Relatedly, mothers who smoke in the United States are more likely to have low education, which increases the risk for childhood adiposity (Ruiz et al., 2016) . Thus, income and education are potential confounds in the association between PTE and later obesity risk, which underscores the need for including matched control groups when examining PTE effects. Third, there is a dearth of knowledge on the effects of the timing of PTE exposure for later obesity risk with only one of the seven previous studies examining exposure in each trimester (Chen et al., 2006) . However, in this study, the trimester data varied across the women depending on when they registered for prenatal care, making it difficult to disentangle the effects of timing of exposure (Chen et al., 2006) . Taken together, no single study, to our knowledge, has prospectively examined dose-response and timing of exposure effects on rapid weight gain in the toddler period using multiple methods to assess PTE with a demographically matched control group. It is critical to assess the link between PTE and obesity risk in the toddler period and early childhood given that children's trajectories of later obesity risk appear to be set by age 6 years and in light of recent calls for early prevention efforts (Gillman & Ludwig, 2013; Von Kries, Muller, and Heinrich, 2014) .
Current Study
The purpose of this prospective study was to extend research on PTE and rapid weight for length gain in the toddler period as indicated by CWFLG by 2 years of life using multiple methods to measure PTE, to examine dose-response and timing effects, while controlling for demographic risks in research design. A secondary aim was to explore the effects of continued postnatal exposure on CWFLG. Specifically, we hypothesized that PTE would be associated with greater CWFLG over the first 2 years of life; that higher doses of PTE would be associated with greater CWFLG; and given rapid fetal growth in the third trimester, there would be stronger effects for third trimester exposure compared with the first two trimesters or overall pregnancy exposure. Given lack of prior evidence, we had no specific hypothesis for postnatal exposure, but examined whether postnatal exposure contributed to CWFLG after accounting for PTE.
Method

Sample Selection
Pregnant women between 12-and 20-weeks' gestation who presented for care at a large urban hospital's prenatal clinic serving a large number of low-income women were asked to complete a screening form during their first prenatal appointment. If determined to be initially eligible by the screening form, women were invited to participate in a face-to-face interview by the end of the first trimester to determine eligibility, and if eligible, were asked to participate in an ongoing longitudinal study of maternal health and child development by a research assistant for the study. At the end of each month of recruitment, the closest matching nonsmoker (based on age and education) was invited to participate. Smokers were oversampled so that one nonsmoker was recruited for every two smokers (taking the average of maternal age and education of both). Women who agreed to participate were scheduled for three appointments during pregnancy that corresponded with the end of each trimester. Please see Figure 1 for eligibility criteria and to determine how we reached our final sample of 174 for the Tobacco Exposure and Conditional Weightcurrent study that primarily consisted of young, unmarried, minority women with low education (see Table I ). Of these, 117 were smokers and 57 were nonsmokers.
Procedure
Informed written consent was obtained from interested, eligible women at their first laboratory visit during the first trimester of pregnancy. The study protocol was approved by the Children and Youth Institutional Review Board at the State University of New York. Participants were informed that data confidentiality was protected by a Federal Certificate of Confidentiality issued by the National Institute on Drug Abuse. Participants received payments for completed assessments, totaling $370 in money along with gift cards and infant toys across seven visits from their first prenatal visit to their visit at 24 months child age.
Study Measures
Anthropometrics and CWFLG Anthropometric measurements were taken by trained research staff, blinded to group status. A calibrated scale was used to measure toddler weight, measured to the nearest 0.001 kg (SECA, Hamburg, Germany). Toddler length was measured in the supine position at 2, 9, and 16 months using an infantometer (SECA, Hamburg, Germany). Toddler height was measured in the standing position at 24 months after removing shoes and socks using a calibrated stadiometer measured to the nearest 0.01 cm (SECA, Hamburg, Germany). Toddlers' measured weight and length/height were converted to zscores adjusted for age and sex using the World Health Organization growth standards (WHO Multicentre Growth Reference Study Group, 2006) . A z-score refers to the number of standard deviations the measurement lies above or below the mean or average score. CWFLG z-scores were calculated as the standardized residuals from the linear regression of the 24-month weight-forlength z-score on birthweight for length z-score, with age and sex entered as covariates. The standardized residual is the 24-month weight-for-length z-score minus its value predicted from the regression, divided by the residual standard deviation from the regression. Thus, one advantage of using CWFLG is that it accounts for the potential confounding influence of birthweight for length, age, and sex. The CWFLG z-score has a mean of 0 and a standard deviation of 1 and is normally distributed. Positive values denote a more rapid rate of weight gain for length, and negative values a slower rate of weight gain for length, compared with the average population weight gain for length among toddlers of the same age and sex.
Maternal Prenatal Substance Use PTE Group Status PTE group status (presence/absence) was determined through a combination of self-report, meconium, and maternal saliva samples taken once in each trimester of pregnancy.
Maternal Self-Report Measures
At each prenatal and postnatal visit, the Timeline Follow-Back Interview (Sobell & Sobell, 1992 ) was used to gather daily tobacco, alcohol, and cannabis use for the previous 3 months. Participants were provided a calendar and asked to identify events of personal interest (e.g., holidays, birthdays, vacations) as anchor points to aid recall. The method was established as a reliable and valid method of obtaining data on substance use patterns including cigarettes, has good test-retest reliability, and is highly correlated with other intensive self-report measures (Brown et al., 1998) . This measure yielded data on average number of cigarettes smoked per day, average number of drinks per day, and average number of joints per day during each trimester and overall pregnancy.
Maternal Salivary Assessments
Maternal saliva was collected at each prenatal visit to provide objective evidence of recent substance exposure. Saliva specimens were analyzed by the U.S. Drug Testing Laboratory (Des Plaines, IL) for cotinine. Cotinine, the primary metabolite of nicotine, was assayed with ELISA or liquid chromatography-tandem mass spectrometry (LC-MS/MS), and a 10 mg/L cutoff was used for both assay methods (Jarvis, Fidler, Mindell, Feverabend, & West, 2008) . Maternal salivary cotinine ranged from 0 to 569 mg/L of saliva.
Fetal Exposure During the Third Trimester (infant meconium) After birth, meconium specimens were collected from soiled diapers twice daily until the appearance of milk stool, transferred to storage containers, and frozen until transport to the National Institute on Drug Abuse for analysis. Meconium specimens were assayed with a validated LC-MS/MS method for the presence of nicotine, cotinine, or trans-3-hydroxycotinine as evidence of fetal nicotine exposure (Gray et al., 2010) . A continuous measure of fetal exposure was also derived by taking the sum of nano moles/g of all three nicotine markers in infant meconium. Mother-infant dyads were assigned to the PTE group if mothers reported smoking cigarettes after conception, had salivary cotinine levels greater than 10 mg/L in any trimester of pregnancy, and/or infants had any tobacco metabolites in their meconium.
Child postnatal exposure (toddler salivary samples) Toddler postnatal exposure was assessed during the 2-, 9-, and 24-month visits with infant saliva samples. Salivary cotinine concentrations are highly correlated to those in the blood (Jarvis, Primatesta, Erens, Feyerabend, & Bryant, 2003) and, thus, are an accurate, yet noninvasive, way of measuring postnatal exposure. Toddler saliva samples were collected by placing eye spears (BD Opthalmology "Visispears" [product #581089], marketed by Salimetrics as "Sorbettes" [product #5029]) in the mouth of toddlers. These samples were placed in a storage vial and immediately placed in À80 C freezer and sent to the Center for Interdisciplinary Salivary Bioscience at Johns Hopkins University for assay. The benefit of saliva testing is that it quantifies exposure to cigarette smoke from all possible sources including other household smokers. Total passive exposure was calculated by averaging these measures.
Potential Confounds. Potential covariates were identified from the literature a priori. Maternal age, years of education, race (Caucasian vs. not Caucasian), parity (number of live births), prenatal substance use other than tobacco (i.e., alcohol and marijuana use), total number of breastfeeding days up to 24 months of child age, and prenatal maternal depression (Brief Symptom Inventory, Derogatis & Melisaratos, 1983) were assessed via maternal self-report. Prepregnancy maternal BMI, infections or other acute medical problems during pregnancy and maternal chronic disease with onset before pregnancy (the most common of which were herpes and human papilloma virus in our sample) were obtained from medical records.
Missing Data. As with any prospective study, there were data missing at different time points. With regard to covariates, 1.7% (n ¼ 3) of the women were missing data on prepregnancy BMI, and 11% (n ¼ 19) were missing data on parity. Among toddlers, 17% (n ¼ 29) did not have meconium data. Those missing data on meconium versus not did not differ on any of the model variables with the exception of third trimester smoking (t (111.91) ¼ 2.37, p ¼ .02, d ¼.45), and race (v 2 (1) ¼ 5.22, p ¼ .02). Toddlers missing meconium data had mothers who smoked less during their third trimester and were more likely to be Caucasian compared with toddlers with meconium data. Race and timing of exposure were included in analyses. Given patterns of missingness on exogenous variables (meconium, prepregnancy BMI, and parity), multiple imputation (with 10 copies of sample data set) was used to address missing data. This is considered to be the state-of-the-art method for handling missing data and it performs well even when data are nonnormal using MPLUS 7.2 software (Enders, 2006; Schafer & Graham, 2002) . Maximum likelihood estimation procedures with standard errors and chi-square statistic robust to nonnormality were used to estimate all parameters of interest.
Results
Descriptive Information and Bivariate Correlations
Differences between pregnant smokers and nonsmokers on study variables are presented in Table I for descriptive purposes.
Chi-square tests of independence indicated that there were no significant differences between the two groups with respect to infections or other acute medical problems during pregnancy (v (1) ¼ 6.68, p ¼ .01), such that Caucasian women were more likely to smoke while pregnant than nonCaucasian women.
PTE and Restricted Growth at Birth
Bivariate correlations revealed that maternal reports of number of cigarettes per day across pregnancy and average number of cigarettes smoked per day during first, second, or third trimesters were not associated with birthweight (r's ranged from (À.09) to (À.11), all p's ! .15). However, fetal exposure to tobacco in the third trimester was predictive of restricted growth at birth, such that infants with higher levels of nicotine and metabolites in their meconium had lower birthweights than infants with lower levels of nicotine and metabolites in their meconium (r ¼ À.24, p ¼ .003). Similarly, although maternal self-reports were not associated with small-for-gestational-age (SGA) status (r's ranged from .00 to .07, p's ! .39), there was a significant positive association between amount of nicotine and metabolites in infant meconium and SGA status, such that infants with higher levels of fetal exposure to PTE were more likely to be SGA (r ¼ .19, p ¼ .024).
PTE and BMI at 2 Years of Child Age
Results indicated that 4% (n ¼ 7) of the mothers were considered to be underweight (i.e., BMI < 18.5), 33% (n ¼ 56) were normal or healthy weight (i.e., BMI between 18.5 and 24.9), 30% (n ¼ 52) were overweight (i.e., BMI between 25 and 29.9), and 33% (n ¼ 56) were obese (i.e., BMI of !30) prepregnancy. Concerning their progeny, 44% (n ¼ 76) of the toddlers at 24 months of age were normal or healthy weight (i.e., <85th percentile), 24% (n ¼ 42) were overweight (between the 85th and the 94th percentile), and 32% (n ¼ 56) were obese (i.e., >95th percentile) (see . Descriptive information and bivariate correlations are in Table II .
Regression Analyses
Regression analyses predicting CWFLG at 24 months child age from tobacco exposure measures and the potential confounds listed above were conducted using Mplus, Version 7.2 software (Muthen & Muthen, 1998 . We also conducted a regression analysis predicting CWFLG at 24 months child age from postnatal exposure, accounting for the covariates and PTE. PTE toddlers did not differ from non-PTE toddlers in CWFLG (unstandardized beta (b) ¼ þ.14, standardized beta (b) ¼ þ .06, p ¼ .37, 95% CI [À0.08, 0.20]). However, there were significant doseresponse associations. After accounting for covariates, higher average number of cigarettes per day during pregnancy predicted higher CWFLG by 2 years
That is, an increase of an average of one cigarette per day was associated with an increase of 0.04 standard deviations in CWFLG. With regard to timing of exposure, average number of cigarettes per day during tri- Note. n ¼ 174. ***p < .001, **p < .001, *p .05, tp < .10. CWFLG ¼ Conditional weight-for-length gain; BMI ¼ body mass index; PTE group status ¼ prenatal tobacco exposure group status (0 ¼ not exposed, 1 ¼ exposed); Cigs per day ¼ average number of cigarettes smoked per day across pregnancy; Cigs per day Tri 1 ¼ average number of cigarettes smoked per day during the first trimester of pregnancy; Cigs per day Tri 2 ¼ average number of cigarettes smoked per day during the second trimester of pregnancy; Cigs per day Tri 3 ¼ average number of cigarettes smoked per day during the third trimester of pregnancy; Meconium ¼ amount of nicotine metabolites in meconium; Race was coded 0 ¼ Not Caucasian, 1 ¼ Caucasian; Joint per day ¼ average number of marijuana joints smoked per day across pregnancy; Alcohol per day ¼ average number of alcoholic drinks consumed per day across pregnancy. Acute medical problems ¼ infections or other acute medical problems during pregnancy; Maternal chronic disease ¼ maternal chronic disease with onset before pregnancy.
respect to fetal exposure (infant meconium), results indicated that higher levels of nicotine metabolites in meconium predicted greater CWFLG by 2 years
Thus, a 1-unit increase in nicotine metabolites in meconium (nano moles/g), which is a marker of third trimester fetal exposure, was predictive of an increase in CWFLG of 0.28 standard deviations. Postnatal exposure was not related to CWFLG, controlling for meconium ( 
Discussion
Higher dose of PTE, as indicated by maternal report and infant meconium, and exposure to tobacco during the last two trimesters of pregnancy were prospectively predictive of more rapid CWFLG over the first 2 years of life. Notably, presence or absence of exposure was not predictive of greater CWFLG, suggesting that exposure alone is not sufficient to increase obesity risk. Our results accord with the prenatal origins of health and illness hypothesis, which posits that events during the prenatal period are critical for later health (Barker, 1992; Coe & Lubach, 2008) . Our findings are also in line with animal studies showing that PTE is linked with greater obesity risk in rats and with alterations in appetite and satiety in rhesus macaques via alterations in hypothalamic functioning (Gao et al., 2005; Somm et al., 2008) .
Many studies of PTE and obesity risk are based on retrospective, single-item measures of exposure and no control for variables such as maternal age and education in research design. Our results indicate that retrospective, single-item approaches may underreport the potential association between PTE and obesity risk. Although PTE group status based on prospective data collected using multiple measurement methods was not associated with obesity risk, dose-response emerged as a significant predictor of obesity risk in later trimesters. Not only do these findings demonstrate an association between PTE and toddler obesity risk, they also highlight the utility of taking a more nuanced assessment approach when conceptualizing and researching pre-and postnatal tobacco exposure as obesity risk factors. Accurate assessment of tobacco use both prenatally and postnatally is complex, underscoring the importance of multiple measurement methods. Pregnant and postpartum women are often reluctant to disclose substance use information. In addition, retrospective measures may be problematic owing to significant recall bias. Thus, future studies of obesity risk measuring continuous dose-response associations using multiple methods may be better able to advance the field.
Prenatal exposure science is based on the principle of an association between amount of exposure and the subsequent response or reaction. There is also discussion in this field of threshold effects, a dose below which exposure may not be associated with a response. Our results indicate that mere exposure may not be associated with obesity risk. Thus, the threshold of any versus none was not a significant risk factor for CWFLG. Rather, the greater the level of exposure, the greater the risk for obesity as indicated by CWFLG over the first 2 years of life. Thus, any reductions in amount of cigarettes used during pregnancy may reduce risk for obesity as indicated by less rapid increase in CWFLG in the first 2 years of life. Our results suggest that interventions aimed at reducing risk by decreasing the amount of cigarettes smoked during pregnancy may also lead to reductions in toddlers' obesity risk.
In line with former studies , our findings also highlight the significance of studying the timing of PTE when predicting CWFLG. However, in contrast to studies demonstrating associations between early pregnancy smoking (i.e., first trimester) and later obesity risk (Toschke, Montgomery, Pfeiffer, & von Kries, 2003) , our results indicate that only second and third trimester PTE predict CWGFL by 2 years. These findings are consistent with previous work demonstrating that smoking throughout pregnancy, and especially later in pregnancy, is associated with later obesity risk (Chen et al., 2006; Fasting et al., 2009) , and are supported by both self-report and objective measures of nicotine use. Our results, in conjunction with previous research documenting that some mothers increase their smoking after an initial reduction on pregnancy recognition (Eiden et al., 2013) , suggest that additional interventions may be beneficial to low-income pregnant smokers who may need more assistance in their attempts to reduce the number of cigarettes in the second and third trimesters.
Finally, we tested whether continued postnatal exposure predicted CWFLG by 2 years given that the majority of women who smoke during pregnancy continue to smoke in the postnatal period (Shisler, Homish, Molnar, & Eiden, 2016) and are more likely to live in households with other smokers (Penn & Owen, 2002) . We also examined the role of postnatal exposure because both prenatal and postnatal exposure have been associated with increased risk of obesity in the literature (Pagani, Nguyen, & Fitzpatrick, 2015; Raum et al., 2011) . Results indicated that postnatal exposure was not associated with CWFLG. There may be several explanations for this. First, postnatal exposure can only be examined in the context of prenatal exposure in young children, as many women who smoke postnatally also smoked prenatally or had family members who smoked around them while they were pregnant. Given the strong association between prenatal and postnatal exposure, it is possible that there were issues regarding multicollinearity, such that passive exposure did not account for additional variance after controlling for prenatal exposure. Second, passive exposure may be a more significant predictor of CWFLG among children who had no prenatal exposure (e.g., among mothers who quit during pregnancy, but relapsed postpartum). By design, these women were excluded from our study. To examine the effects of passive exposure alone, it may be necessary to study women who had quit smoking in early pregnancy, did not have partners or other household members who smoked, remained abstinent until delivery, but relapsed postpartum.
The findings from this study must be interpreted within the context of its limitations. First, our results are limited to CWFLG, as we did not include other measures of body composition, such as number of skinfolds or skinfold thickness. Although CWFLG has been established as an important marker of later obesity risk and has the advantage of taking into account the effects of child sex and birthweight, it does not differentiate between fat mass and fat-free mass, which can provide a more nuanced understanding of the effects of PTE on later obesity risk (Harrod et al., 2014a) . Second, although we were able to statistically account for many relevant covariates, such as prepregnancy BMI, other substance use, duration of breastfeeding, and maternal health during pregnancy, we were not able to account for gestational weight gain or toddler dietary behavior. Thus, this work should be replicated accounting for these key factors. Despite these limitations, this study adds to the growing body of literature, indicating the importance of examining prenatal origins of health and disease and examining rapid weight gain in early childhood. Strengths of the current study include the prospective design, dose-response, and timing of PTE effects for specific trimesters of pregnancy, multiple methods to measure PTE, and use of neonatal meconium as a marker of fetal exposure Conclusions PTE is related to restricted growth at birth, yet associated with accelerated CWFLG by 2 years of child age. Specifically, results demonstrated that PTE group status alone was not associated with greater CWFLG. However, there was a dose-response relationship between PTE and more rapid CWFLG by 2 years, such that second and third trimester PTE predicted accelerated CWFLG. Finally, our results underscore the importance of fetal exposure of PTE during the third trimester, as indicated by amount of nicotine metabolites in meconium, but we found no support for the role of postnatal exposure in the context of prenatal exposure. Results highlight the importance of interventions aimed at reducing smoking throughout pregnancy, with continued interventions toward the end of pregnancy when some women begin to relapse or increase smoking, as well as the timing of obesity risk prevention on the first 2 years of life.
Notes
1
Given evidence indicating that growth trajectories of preterm infants significantly differ from full-term infants (Sullivan, McGrath, Hawes, & Lester, 2008) , we excluded 16 toddlers from further analyses because of prematurity (i.e., <37 weeks gestational age); 2 measurement error in height and weight was detected by the macro used to calculate BMI provided by the WHO (http://www.who.int/childgrowth/software/en/).
